Annual report [Section 13 and 15(d), not S-K Item 405]

Warrants

v3.25.1
Warrants
 12 Months Ended
Dec. 31, 2024
Warrants [Abstract]  
Warrants Warrants
The following table represents a summary of warrants to purchase shares of the Company’s common stock that are outstanding:
Warrant Issue Date Outstanding as of December 31, 2024 Exercise Price Expiration
June 2020 - November 2020 54
$1,506,600 - $6,277,500
 June 2025 - November 2025
January 2021 - December 2021 16
 $1,701,000 - $7,593,750
 January 2026 - December 2026
July 2022 - October 2022 24
$432,000 - $1,755,000
 July 2027 - October 2027
January 2023 10
$434,700
 January 2028
February 2023 21
$432,000
 October 2027 - February 2028
June 2023 57
 $199,530 - $207,630
June 2028
March 2024 35
$2,115
 March 2029
July 2024 2,334
$398
 July 2029
August 2024 4,003
$285 - $303
 August 2029
Preferred Stock Warrants
On February 2023, the Company granted warrants to purchase 45,000 shares of Series E preferred stock with the original exercise price of $0.50 and expiration date of February 2028. The warrants to purchase 45,000 shares of Series E preferred stock remain outstanding as of December 31, 2024.
2024 Warrant Exchange
On September 18, 2024, the Company entered into two Warrant Exchange Agreements (collectively, the “2024 Warrant Exchange”) with two investors to exchange three warrants issued between 2018 and 2022 into a total of 334 shares of common stock. The 2024 Warrant Exchange was treated as a modification in accordance with ASC 718, Compensation - Stock Compensation, and the Company recognized $0.1 million in selling, general and administrative expense related to the 2024 Warrant Exchange during the year ended December 31, 2024.